Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02125253 | Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis | PHASE3 | COMPLETED | 811 | — | — | Jan 1, 2014 | Jun 1, 2014 | Nov 2, 2015 | 10 | United States |
Change from baseline in average AM/PM reflective Total Nasal Symptom Score (rTNSS) over Days 1 to 14
The sum of patient-rated severity scores for four allergy symptoms : runny nose, nasal congestion, itchy nose, and sneezing based on a 4-point scale.
| Arm | Type | Description |
|---|---|---|
| Mometasone Furoate Nasal Spray, 50 mcg | EXPERIMENTAL | Mometasone Furoate Nasal Spray, 50 mcg. 4 actuations per day for 14 days. |
| Nasonex Nasal Spray, 50 mcg | ACTIVE_COMPARATOR | Nasonex (mometasone furoate monohydrate) Nasal Spray, 50 mcg. 4 actuations per day for 14 days. |
| Placebo Nasal Spray | PLACEBO_COMPARATOR | Placebo of Mometasone Furoate Nasal Spray. 4 actuations per day for 14 days. |
| Name | Type | Description |
|---|---|---|
| Mometasone Furoate Nasal Spray, 50 mcg | DRUG | a metered-dose, manual pump spray unit containing an aqueous suspension of mometasone furoate |
| Nasonex Nasal Spray, 50 mcg | DRUG | a metered-dose, manual pump spray unit containing an aqueous suspension of mometasone furoate monohydrate |
| Placebo Nasal Spray | DRUG | a metered-dose, manual pump spray unit containing an aqueous suspension |
Inclusion Criteria: * If female and of child-bearing potential, have a negative urine pregnancy test and is prepared to abstain from sexual intercourse or use a reliable method of contraception during the study * Documented positive allergic skin test, performed within the previous 12 months, to on...